A Study of Cognitive Function in Patients with Macular Degeneration and Glaucoma


About this study

The purpose of this study is to determine the prevalence and severity of cognitive dysfunction in patients with wet, dry macular degeneration and glaucoma.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults, age > 18 years old.
  • Subjects with wet and dry macular degeneration.
  • Note:  Patients with all levels of cognitive ability will be enrolled.

Exclusion Criteria: 

  • Patients who do not speak English.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Cheryl Khanna, M.D.

Open for enrollment

Contact information:

Elainey Wada

(507) 538-4122


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer